Cargando…
Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma
BACKGROUND: Inflammatory mediators may have decisive roles at different stages of tumour development. Mediators within the pentraxin family may be used as strong biomarkers in prognosis of advanced pancreatic carcinoma patients. METHODS: Using pancreatic carcinoma cell lines and gene transfectant, w...
Autores principales: | Kondo, S, Ueno, H, Hosoi, H, Hashimoto, J, Morizane, C, Koizumi, F, Tamura, K, Okusaka, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738116/ https://www.ncbi.nlm.nih.gov/pubmed/23828517 http://dx.doi.org/10.1038/bjc.2013.348 |
Ejemplares similares
-
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
por: Kondo, Shunsuke, et al.
Publicado: (2012) -
Clinical significance of midkine expression in pancreatic head carcinoma
por: Maeda, S, et al.
Publicado: (2007) -
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
por: Häyry, V, et al.
Publicado: (2010) -
High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008) -
Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis
por: Voorneveld, P W, et al.
Publicado: (2013)